Homepage
PR Newswire
16-09-2015, 11:35 AM
Tried to look for this company in vb, but could not find the thread.
From google finance data, this medical company listed in HKSE (code: 2877) seems to have reasonable ROE and reasonable valuation.
Major shareholder and chairman: Li Zhen jiang
Mr. Zhenjiang Li Co-Founded China Shineway Pharmaceutical Group Limited and serves as its Executive Chairman and President. Mr. Li joined the predecessor of China Shineway Pharmaceutical in 1974 and has been its Chairman and President since 1984 with responsibility for business development and strategy. Mr. Li has more than 20 years' experience in the operation and management of modern Chinese medicine enterprises. Mr. Li serves as Vice-chairman and Director of the PRC Chinese Medicine Association. Mr. Li takes charge of the overall management of the Group and is also specifically responsible for the Group's research and development activities. Mr. Li is a Representative to the 10th National People's Congress and to the 7th, 8th and 9th Hebei Province People's Congress. Mr. Li has been an Executive Director of China Shineway Pharmaceutical Group Limited since October 15, 2002. He has been named as an Outstanding Entrepreneur in the PRC Pharmaceutical Industry in 1994, and as a China Outstanding Young Entrepreneur in 1995 and has received a National Wu Yi Labour Award. Mr. Li obtained a diploma in Chemical Mechanics from Hebei Province Chemical Industrial Institute in 1982 and in 1989 graduated from the Modern Management Institute where he majored in Industrial Business Administration. He obtained an EMBA at the Yangtze Commercial Institute in 2006.
====
China Shineway Pharmaceutical Group Limited is an investment holding company. The Company’s subsidiaries are engaged in the research, development, manufacturing and trading of modern Chinese medicines. The Company’s products mainly consist of Qing Kai Ling Injection, used for treatment of viral diseases; Shen Mai Injection, used for treatment of coronary heart disease, viral myocarditis and pulmonary heart disease; Shu Xie Ning Injection, used for treatment of cardio-cerebrovascular disease; Wu Fu Xin Nao Qing Soft Capsule, used for prevention and treatment of coronary heart disease and cerebral arteriosclerosis; Pediatric Qing Fei Hua Tan Granule, used for for children infected by respiratory related disease, and Huo Xiang Zheng Qi Soft Capsule, used for for prevention and treatment of heat stroke, stomachache, nausea and diarrhoea, acclimatization sickness.
Address
Luancheng
SHIJIAZHUANG, HEB 051430
China
+86-311-88030066 (Phone)
+86-311-88030088 (Fax)
Anybody has any idea on the reputation of the chairman and trustworthiness of the company?
thanks
From google finance data, this medical company listed in HKSE (code: 2877) seems to have reasonable ROE and reasonable valuation.
Major shareholder and chairman: Li Zhen jiang
Mr. Zhenjiang Li Co-Founded China Shineway Pharmaceutical Group Limited and serves as its Executive Chairman and President. Mr. Li joined the predecessor of China Shineway Pharmaceutical in 1974 and has been its Chairman and President since 1984 with responsibility for business development and strategy. Mr. Li has more than 20 years' experience in the operation and management of modern Chinese medicine enterprises. Mr. Li serves as Vice-chairman and Director of the PRC Chinese Medicine Association. Mr. Li takes charge of the overall management of the Group and is also specifically responsible for the Group's research and development activities. Mr. Li is a Representative to the 10th National People's Congress and to the 7th, 8th and 9th Hebei Province People's Congress. Mr. Li has been an Executive Director of China Shineway Pharmaceutical Group Limited since October 15, 2002. He has been named as an Outstanding Entrepreneur in the PRC Pharmaceutical Industry in 1994, and as a China Outstanding Young Entrepreneur in 1995 and has received a National Wu Yi Labour Award. Mr. Li obtained a diploma in Chemical Mechanics from Hebei Province Chemical Industrial Institute in 1982 and in 1989 graduated from the Modern Management Institute where he majored in Industrial Business Administration. He obtained an EMBA at the Yangtze Commercial Institute in 2006.
====
China Shineway Pharmaceutical Group Limited is an investment holding company. The Company’s subsidiaries are engaged in the research, development, manufacturing and trading of modern Chinese medicines. The Company’s products mainly consist of Qing Kai Ling Injection, used for treatment of viral diseases; Shen Mai Injection, used for treatment of coronary heart disease, viral myocarditis and pulmonary heart disease; Shu Xie Ning Injection, used for treatment of cardio-cerebrovascular disease; Wu Fu Xin Nao Qing Soft Capsule, used for prevention and treatment of coronary heart disease and cerebral arteriosclerosis; Pediatric Qing Fei Hua Tan Granule, used for for children infected by respiratory related disease, and Huo Xiang Zheng Qi Soft Capsule, used for for prevention and treatment of heat stroke, stomachache, nausea and diarrhoea, acclimatization sickness.
Address
Luancheng
SHIJIAZHUANG, HEB 051430
China
+86-311-88030066 (Phone)
+86-311-88030088 (Fax)
Anybody has any idea on the reputation of the chairman and trustworthiness of the company?
thanks